Home >> WEBINARS >> Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

Endeavor to leave no patient behind: Next-generation sequencing (NGS) in routine NSCLC biomarker testing

Print Friendly, PDF & Email

Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Boaz Kurtis, MD

What will this webinar empower you to do?

  • To learn the how and why of NGS testing for NSCLC therapy selection
  • How to practice precision oncology based on fast-changing guidelines and to ensure even challenging samples get tested to achieve best outcomes for as many NSCLC patients as possible
  • Cancer Genetics Inc. (CGI) testing model, case studies and lessons learned

Originally broadcast: March 28, 2018

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Thermo Fisher.

x

Check Also

Homologous recombination deficiency and BRCA testing in ovarian and breast cancer

Webinar presenters Dana Chase, MD,  Michelle Shiller, DO, and Tabetha Sundin, PhD discuss the role of BRCA1/2 mutations in homologous recombination deficiency and carcinogenesis, homologous recombination deficiency as a marker of treatment sensitivity, the testing process for homologous recombination deficiency and BRCA mutations, and the role of BRCA testing in ovarian and breast cancer. This on-demand webinar originally broadcast on October 23, 2018.

X